The cost of obesity in radical cystectomy.

2019 ◽  
Vol 37 (7_suppl) ◽  
pp. 434-434 ◽  
Author(s):  
Melissa Huynh ◽  
Ye Wang ◽  
Daniel Pucheril ◽  
Dimitar V. Zlatev ◽  
Steven Lee Chang ◽  
...  
Keyword(s):  
Radical Cystectomy ◽  
Operative Time ◽  
Financial Burden ◽  
Morbidly Obese ◽  
Obese Patients ◽  
Index Hospitalization ◽  
Healthcare Database ◽  
Quantile Regression Analysis ◽  
The Cost ◽  
The Impact

434 Background: The Centers for Disease Control and Prevention estimates that nearly 40% of the U.S. population meets the criteria for obesity classification. Several studies have shown that obesity is associated with increased medical morbidity and costs. In this study, we investigated the impact of obesity on the financial burden of radical cystectomy. We hypothesize that the cost of radical cystectomy is greater in obese and morbidly obese patients compared to overweight patients. Methods: We performed a retrospective observational study within the Premier Healthcare Database (Premier Inc., Charlotte, NC), a large, U.S. hospital-based, all-payer database representing approximately 20% of annual inpatient discharges. ICD-9 procedure codes were used to identify all patients who had undergone elective radical cystectomy (57.71, 57.79) from 2003 to 2015, and administrative data was used to extract the costs associated with the index hospitalization. Patients were stratified into three body mass index (BMI) categories: overweight (25 BMI <30), obese (30 ≤ BMI < 40) and morbidly obese (BMI ≥ 40). Quantile regression analysis was performed to examine the effect of BMI category on cost. Results: We identified 12,056 patients who underwent radical cystectomy, 1,406 of whom had data available regarding BMI category. The crude cost of the index hospitalization for radical cystectomy was $24,596 for overweight patients. The costs associated with patients in the obese and morbidly obese categories were $2,158 ( p=0.059) and $5,308 ( p<0.001) higher compared to overweight patients, respectively. Median operative time for overweight, obese, and morbidly obese patients was 346, 391, and 420 minutes, respectively (p=0.0001). Multivariable models were constructed controlling for clinicodemographic, and surgical factors. After adjustment for operative time, there were no longer any statistically significant differences in cost between the BMI categories. Conclusions: The cost of radical cystectomy is significantly greater for obese and morbidly obese patients compared to overweight patients. This increased financial cost associated with obesity difference is driven by increased operative times encountered in obese patients.

scholarly journals Towards Precision Health in Weight Reduction: Thematic Content Analysis of an Open-Ended Survey on Reasons Why Morbidly Obese Patients Want to Lose Weight.

2020 ◽  
Author(s):  
Mazapuspavina Md-Ya ◽  
Ilham Ameera Ismail ◽  
Khasnur Abd Malek ◽  
Khalid Yusoff ◽  
Awang Bulgiba
Keyword(s):  
Morbid Obesity ◽  
Weight Loss ◽  
Content Analysis ◽  
Weight Reduction ◽  
Extensive Study ◽  
Morbidly Obese ◽  
Obese Patients ◽  
Thematic Content Analysis ◽  
Thematic Content ◽  
The Impact

Abstract Background: Addressing individuals’ motivation to lose weight among patients with morbid obesity is an essential entity in weight reduction. Failures to shift motivation into weight loss actions are common. These could be contributed by the inadequacy to identify and subsequently address the key reasons, that are of particular concern to the patient' individual needs. We aimed to understand the motivations better and identify the reasons why morbidly obese patients attending hospital-based weight management programmes (WMP) wanted to lose weight. Methods: The study used a qualitative approach to analyze part of a quantitative questionnaire of a more extensive study to understand factors influencing weight loss among morbidly obese patients. We used thematic content analysis to analyze responses from a self-administered open-ended question "What is the main factor why you want to lose your weight?”. A total of 225 new patients attending obesity clinics in two tertiary hospitals responded to the questionnaire. Results: Patients’ mean BMI was 45.6±8.05 kg/m2. Four themes emerged for the reasons why morbidly obese patients wanted to lose weight. Health was the most commonly inferred theme (84%). Patients were concerned about the impact obesity had on their health. Overcoming obesity was seen as a reward not just for physical health, but also for their psychological wellbeing. Patients regard being functional to care for themselves, their family members, as well as their religious and career needs as the next most crucial theme (25.8%). Patients raised the theme appearance (12.9%), especially with regards to wanting to look and feel beautiful. The last theme was perceived stigmatization for being morbidly obese as they were mocked and laughed at for their appearance (3.1%).Conclusion: Patients with morbid obesity in this study had expressed their main personal motivational reasons to lose weight. Concerns about the impact of morbid obesity on health, physical, social and obligatory function, appearance and perceived stigma warrant detailed exploration by the managing health professionals. Identifying and addressing these unique personal motivations in a focused approach is vital at the beginning and throughout a weight reduction program in this unique group.

scholarly journals Impact of obesity on male urethral sling outcomes

2020 ◽  
Vol 12 ◽  
pp. 175628722092799
Author(s):  
M. Francesca Monn ◽  
Hannah V. Jarvis ◽  
Thomas A. Gardner ◽  
Matthew J. Mellon
Keyword(s):  
Operative Time ◽  
Cohort Analysis ◽  
Obese Patients ◽  
Retrospective Cohort Analysis ◽  
Surgical Complexity ◽  
History Of ◽  
Sling Placement ◽  
The Impact ◽  
Male Urethral Sling

Background: The impact of obesity on AdVance male urethral sling outcomes has been poorly evaluated. Anecdotally, male urethral sling placement can be more challenging due to body habitus in obese patients. The objective of this study was to evaluate the impact of obesity on surgical complexity using operative time as a surrogate and secondarily to evaluate the impact on postoperative pad use. Methods: A retrospective cohort analysis was performed using all men who underwent AdVance male urethral sling placement at a single institution between 2013 and 2019. Descriptive statistics comparing obese and non-obese patients were performed. Results: A total of 62 patients were identified with median (IQR) follow up of 14 (4–33) months. Of these, 40 were non-obese and 22 (35.5%) were obese. When excluding patients who underwent concurrent surgery, the mean operative times for the non-obese versus obese cohorts were 61.8 min versus 73.7 min ( p = 0.020). No Clavien 3–5 grade complications were noted. At follow up, 47.5% of the non-obese cohort and 63.6% of the obese cohort reported using one or more pads daily ( p = 0.290). Four of the five patients with a history of radiation were among the patients wearing pads following male urethral sling placement. Conclusion: Obese men undergoing AdVance male urethral sling placement required increased operative time, potentially related to operative complexity, and a higher proportion of obese compared with non-obese patients required postoperative pads for continued urinary incontinence. Further research is required to better delineate the full impact of obesity on male urethral sling outcomes.

scholarly journals Laparoscopic Anti-Reflux Surgery is Effective in Obese Patients with Gastro-Oesophageal Reflux Disease

2007 ◽  
Vol 89 (7) ◽  
pp. 696-702 ◽  
Author(s):  
Vivien V Ng ◽  
Michael I Booth ◽  
Jane J Stratford ◽  
Linda Jones ◽  
J Sohanpal ◽  
...  
Keyword(s):  
Reflux Disease ◽  
Operative Time ◽  
Oesophageal Reflux ◽  
Morbidly Obese ◽  
Obese Patients ◽  
Indications For Surgery ◽  
Body Habitus ◽  
Oesophageal Reflux Disease ◽  
Symptomatic Outcome ◽  
Mean Time

INTRODUCTION Obesity has long been regarded as a risk factor for the development of gastro-oesophageal reflux disease (GORD). It has been claimed that surgical efficacy of laparoscopic anti-reflux operations is decreased in obese patients. The aim of this study was to assess whether laparoscopic anti-reflux surgery is effective in obese patients with GORD compared to non-obese patients. PATIENT AND METHODS A total of 366 patients (mean age 44 years; range, 12–86 years) underwent laparoscopic anti-reflux surgery between 1997–2003. Of these, 74 patients were considered obese; 58 patients had a body mass index (BMI) of 30–34 kg/m2 and 16 were classified as morbidly obese with a BMI ≥ 35 kg/m2. Pre-operative symptomatic scoring, indications for surgery, pH studies, operative times and complications were compared between obese and non-obese patients. Symptomatic outcome and Visick score between the two groups were assessed at 6 weeks, 6 months and 1 year following surgery. RESULTS Failure of medical treatment was the main reason for surgery in all groups. Operative time was longer in obese patients (mean time 93 min compared to 81 min; P = 0.0007), the main difficulty being gaining access because of their body habitus. All groups found the procedure to be effective in symptomatic outcome, 91% of obese patients compared to 92% of non-obese patients scored Visick I or II at 6 weeks' postoperatively. Similar Visick scoring was shown between the two groups at 6 months and 1 year, and in the morbidly obese group. CONCLUSIONS The outcome of laparoscopic anti-reflux surgery is similar between obese and non-obese patients with no trend towards a worse outcome in the obese or morbidly obese. Obesity should not be seen as a contra-indication, although it may be more technically challenging in this group of patients. Good results can be achieved in obese patients.

The Impact of Weight Reduction Surgery on Health-Care Costs in Morbidly Obese Patients

2004 ◽  
Vol 14 (7) ◽  
pp. 939-947 ◽  
Author(s):  
John S. Sampalis ◽  
Moishe Liberman ◽  
Stephane Auger ◽  
Nicolas V. Christou
Keyword(s):  
Health Care ◽  
Health Care Costs ◽  
Weight Reduction ◽  
Morbidly Obese ◽  
Obese Patients ◽  
The Impact ◽  
Care Costs

The Impact of Obesity on the Perioperative, Clinicopathologic, and Oncologic Outcomes of Robot Assisted Total Mesorectal Excision for Rectal Cancer

2017 ◽  
Vol 89 (4) ◽  
pp. 23-28 ◽  
Author(s):  
Ajit Pai ◽  
Fahad Alsabhan ◽  
John J. Park ◽  
George Melich ◽  
Suela Sulo ◽  
...  
Keyword(s):  
Rectal Cancer ◽  
Length Of Stay ◽  
Operative Time ◽  
Statistical Significance ◽  
Oncologic Outcomes ◽  
P Value ◽  
Obese Patients ◽  
Lymph Node Yield ◽  
Conversion Rates ◽  
The Impact

Purpose: To analyze the feasibility and outcomes of robotic rectal cancer surgery in obese patients. Methods: From 2005 to 2012, 101 consecutive rectal cancers operated robotically were enrolled in a prospective database. Patients were stratified into obese (BMI ≥ 30 kg/m2) and non-obese (BMI < 30 kg/m2) groups. Operative, perioperative parameters, and pathologic outcomes were compared. Data were analyzed using SPSS 22.0, while statistical significance was defined as a p value ≤ .05. Results: There were 33 obese patients (mean BMI 33.8 kg/m2). Patients were comparable regarding gender, T stage, and type of operation. Operative time and blood loss were higher in the obese group; only operative time was statistically significant. The conversion rate, length of stay, and anastomotic leak rates were similar. Circumferential margin positivity and lymph node yield were comparable. Disease free and overall survivals at 3 years were 75.8% versus 80.9% and 84.8% versus 92.6%, respectively for obese and non-obese subgroups. Conclusions: Robotic surgery for curative treatment of rectal cancer in the obese is safe and feasible. BMI does not influence conversion rates, length of stay, postoperative complications, and quality of the specimen or survival when the robotic platform is used.

scholarly journals Impact of body mass on hospital resource use in total hip arthroplasty

2009 ◽  
Vol 12 (8) ◽  
pp. 1122-1132 ◽  
Author(s):  
John A Batsis ◽  
James M Naessens ◽  
Mark T Keegan ◽  
Amy E Wagie ◽  
Paul M Huddleston ◽  
...  
Keyword(s):  
Total Hip Arthroplasty ◽  
Resource Utilization ◽  
Hip Arthroplasty ◽  
Tertiary Care ◽  
Obese Group ◽  
Morbidly Obese ◽  
Obese Patients ◽  
Total Hip ◽  
Operative Costs ◽  
The Impact

AbstractObjectiveTo determine the impact of BMI on post-operative outcomes and resource utilization following elective total hip arthroplasty (THA).DesignA retrospective cohort analysis on all primary elective THA patients between 1996 and 2004. Primary outcomes investigated using regression analyses included length of stay (LOS) and costs (US dollars).SettingMayo Clinic Rochester, a tertiary care centre.SubjectsPatients were stratified by pre-operative BMI as normal (18·5–24·9 kg/m2), overweight (25·0–29·9 kg/m2), obese (30·0–34·9 kg/m2) and morbidly obese (≥35·0 kg/m2). Of 5642 patients, 1362 (24·1 %) patients had a normal BMI, 2146 (38·0 %) were overweight, 1342 (23·8 %) were obese and 792 (14·0 %) were morbidly obese.ResultsAdjusted LOS was similar among normal (4·99 d), overweight (5·00 d), obese (5·02 d) and morbidly obese (5·17 d) patients (P= 0·20). Adjusted overall episode costs were no different (P= 0·23) between the groups of normal ($17 211), overweight ($17 462), obese ($17 195) and morbidly obese ($17 655) patients. Overall operative and anaesthesia costs were higher in the morbidly obese group ($5688) than in normal ($5553), overweight ($5549) and obese ($5593) patients (P= 0·03). Operating room costs were higher in morbidly obese patients ($3418) than in normal ($3276), overweight ($3291) and obese ($3340) patients (P< 0·001). Post-operative costs were no different (P= 0·30). Blood bank costs differed (P= 0·002) and were lower in the morbidly obese group ($180) compared with the other patient groups (P< 0·05). Other differences in costs were not significant. Morbidly obese patients were more likely to be transferred to a nursing home (24·1 %) than normal (18·4 %), overweight (17·9 %) or obese (16·0 %) patients (P= 0·001 each). There were no differences in the composite endpoint of 30 d mortality, re-admissions, re-operations or intensive care unit utilization.ConclusionsBMI in patients undergoing primary elective THA did not impact LOS or overall institutional acute care costs, despite higher operative costs in morbidly obese patients. Obesity does not increase resource utilization for elective THA.

scholarly journals Oral conditions and the impact on quality of life of morbidly obese and bariatric patients

2020 ◽  
Vol 68 ◽  
Author(s):  
Rosana Leal do PRADO ◽  
Nataly Dara Moraes SANTOS ◽  
Karina Evangelista da SILVA ◽  
Maria Carolina RODRIGUES ◽  
Jefferson Yoshiharu de Toledo TAGUTI ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Oral Health ◽  
Dental Caries ◽  
Health Impact ◽  
Morbidly Obese ◽  
Obese Patients ◽  
Bariatric Patients ◽  
Oral Conditions ◽  
The Impact

ABSTRACT Objective The aim was to evaluate the prevalence of dental caries, periodontal disease and edentulism in morbidly obese and bariatric patients, and to verify the oral health impact on quality of life. Methods We evaluated 33 morbidly obese patients (G1) and 50 patients submitted to bariatric surgery (G2). The DMFT, CPI, prosthetic status and prosthetic need for edentulism were used to analyze oral conditions. The impact of oral health on quality of life was assessed using the OIDP questionnaire. Results CPOD were G1: 9.0±7.0 and G2: 13.3±8.0 (p= 0.020). The dental calculus was the worst periodontal condition G1: 72.7% and G2: 80.0% (p= 0.752). The majority of G1 and G2 patients did not use (p = 0.878) and did not need (p= 0.132) dental prosthesis. The mean of OIDP was G1: 11.2±23.8 and G2: 14.16±23.8 (p= 0.089). Conclusion It concluded that bariatric patients have a higher prevalence of dental caries and the need for dental prostheses is related to the impact of oral health on the quality of life of obese patients.

scholarly journals 711 Effect of Roux-En-Y Gastric Bypass on HbA1c As Well As Number of Medications in Diabetic Patients

2021 ◽  
Vol 108 (Supplement_6) ◽  
Author(s):  
M Bhandari ◽  
M Rao ◽  
G Bussa ◽  
C Rao
Keyword(s):  
Diabetes Mellitus ◽  
Gastric Bypass ◽  
Glycosylated Haemoglobin ◽  
Morbidly Obese ◽  
Diabetic Patients ◽  
Obese Patients ◽  
The Mean ◽  
The Impact

Abstract Aim Roux en Y gastric bypass (RYGB) is known to ameliorate Type 2 Diabetes Mellitus (T2DM) in morbidly obese patients. We aimed to determine both the reduction in the glycosylated haemoglobin (HbA1c) and the number of anti-diabetic medications (including insulin) in diabetic patients undergoing RYGB over a five-year period. Method We reviewed data of diabetic patients (n = 530) who underwent RYGB from January 2012 – December 2017, including those with a minimum of a 2-year post-operative follow up (n = 47). Preoperatively, BMI, HbA1c and the number of anti-diabetic medications and the duration of T2DM since diagnosis were recorded. These measurements were repeated at the end of the two year follow up. Results At the time of enrolment in the bariatric programme, the median BMI was 42.5 (range, 31.7-61.5) kg/m2, mean duration of T2DM was 58 months and median HbA1c was 59 (37-118) mmol/mol. The mean number of anti-diabetic medications taken, including insulin, was 2. At the end of 2-year follow-up, the median BMI was 32 (range, 24-41) kg/m2 and HbA1c was 41(range, 33-91) mmol/mol. 15 patients (31.9%) still required anti-diabetic medication, 12 of whom had a diagnosis of T2DM for 3 years or more at time of enrolment. Conclusions RYGB is strongly associated with a resolution of T2DM in morbidly obese patients. In those who were not resolved, the number of anti-diabetic medications taken and HbA1c were reduced. The impact of the surgery is dependent on the duration of T2DM since diagnosis preoperatively.

Advancing Knowledge About Sexual Harassment Is a Critical Aspect of Organizational Development for All Employees

2021 ◽  
Vol 11 (4) ◽  
pp. 48-60
Author(s):  
Quatavia McLester ◽  
Darrell Norman Burrell ◽  
Calvin Nobles ◽  
Ileana Castillo
Keyword(s):  
Organizational Culture ◽  
Content Analysis ◽  
Sexual Harassment ◽  
Organizational Development ◽  
Financial Burden ◽  
Sexual Misconduct ◽  
Critical Aspect ◽  
Senior Managers ◽  
The Cost ◽  
The Impact

Sexual harassment remains prevalent in the workplace as well as a significant financial burden for organizations. Given the cost associated with sexual harassment, reputational damage, and internal disturbances, sexual harassment is a mounting apprehension because senior managers are responsible for bestowing an organizational culture that is intolerant to such engrossed behavior. It is imperative to explore how workplace stories and office talk are influenced by organizational culture and how organizational culture affects the workers' perceptions of Me Too and consequences of sexual harassment. Understanding the phenomenon of sexual harassment at work is vital to shaping organizational culture, behavior, and policies aimed at reducing sexual misconduct at work. Existing research indicates that 81% of women and 43% of men have experienced an aspect of sexual harassment. This study uses a content analysis exploration of the literature to better understand the impact and solutions to sexual harassment in the workplace.

scholarly journals Panniculectomy and Cystectomy: An Approach to the Morbidly Obese Patient

2016 ◽  
Vol 2016 ◽  
pp. 1-4
Author(s):  
Lee A. Hugar ◽  
Robert M. Turner ◽  
Jeffrey A. Gusenoff ◽  
Andres F. Correa ◽  
Bruce L. Jacobs ◽  
...  
Keyword(s):  
Body Mass Index ◽  
Obese Patient ◽  
Radical Cystectomy ◽  
Urinary Diversion ◽  
Ileal Conduit ◽  
Morbidly Obese ◽  
Refractory Disease ◽  
Bacillus Calmette Guerin ◽  
Morbidly Obese Patient ◽  
The Impact

The obese patient undergoing radical cystectomy faces a unique set of challenges. We present the case of a 68-year-old gentleman who presented to our institution with Bacillus Calmette-Guerin refractory disease, a body mass index of 38.5, and a large pannus. The present paper describes our technique for performing radical cystectomy with ileal conduit urinary diversion and concomitant panniculectomy. We discuss the impact of obesity on patients undergoing radical cystectomy and how this may be mitigated by panniculectomy.

Sign in / Sign up

Export Citation Format

Share Document